rs145101180

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001165963.4(SCN1A):​c.2421C>T​(p.Phe807Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00109 in 1,613,352 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). The gene SCN1A is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.00084 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0011 ( 10 hom. )

Consequence

SCN1A
NM_001165963.4 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.84

Publications

3 publications found
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 2-166039591-G-A is Benign according to our data. Variant chr2-166039591-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 194359.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.84 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000841 (128/152138) while in subpopulation SAS AF = 0.00749 (36/4806). AF 95% confidence interval is 0.00556. There are 1 homozygotes in GnomAd4. There are 75 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 128 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001165963.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
NM_001165963.4
MANE Select
c.2421C>Tp.Phe807Phe
synonymous
Exon 17 of 29NP_001159435.1P35498-1
SCN1A
NM_001202435.3
c.2421C>Tp.Phe807Phe
synonymous
Exon 16 of 28NP_001189364.1P35498-1
SCN1A
NM_001353948.2
c.2421C>Tp.Phe807Phe
synonymous
Exon 15 of 27NP_001340877.1P35498-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
ENST00000674923.1
MANE Select
c.2421C>Tp.Phe807Phe
synonymous
Exon 17 of 29ENSP00000501589.1P35498-1
SCN1A
ENST00000303395.9
TSL:5
c.2421C>Tp.Phe807Phe
synonymous
Exon 16 of 28ENSP00000303540.4P35498-1
SCN1A
ENST00000375405.7
TSL:5
c.2388C>Tp.Phe796Phe
synonymous
Exon 14 of 26ENSP00000364554.3P35498-2

Frequencies

GnomAD3 genomes
AF:
0.000842
AC:
128
AN:
152024
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000983
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00748
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000794
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00171
AC:
429
AN:
250610
AF XY:
0.00212
show subpopulations
Gnomad AFR exome
AF:
0.0000623
Gnomad AMR exome
AF:
0.000463
Gnomad ASJ exome
AF:
0.00516
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000724
Gnomad OTH exome
AF:
0.000820
GnomAD4 exome
AF:
0.00112
AC:
1635
AN:
1461214
Hom.:
10
Cov.:
36
AF XY:
0.00135
AC XY:
982
AN XY:
726952
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33464
American (AMR)
AF:
0.000470
AC:
21
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00582
AC:
152
AN:
26122
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39648
South Asian (SAS)
AF:
0.00814
AC:
702
AN:
86212
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53412
Middle Eastern (MID)
AF:
0.00417
AC:
24
AN:
5760
European-Non Finnish (NFE)
AF:
0.000585
AC:
650
AN:
1111510
Other (OTH)
AF:
0.00136
AC:
82
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
82
164
246
328
410
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000841
AC:
128
AN:
152138
Hom.:
1
Cov.:
31
AF XY:
0.00101
AC XY:
75
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41542
American (AMR)
AF:
0.000982
AC:
15
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3472
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5176
South Asian (SAS)
AF:
0.00749
AC:
36
AN:
4806
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10562
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000794
AC:
54
AN:
67988
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00108
Hom.:
0
Bravo
AF:
0.000737
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.00109
EpiControl
AF:
0.00101

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Developmental and epileptic encephalopathy (1)
-
-
1
Epilepsy (1)
-
-
1
Generalized epilepsy with febrile seizures plus, type 2 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Migraine, familial hemiplegic, 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_noAF
Benign
-0.35
CADD
Benign
14
DANN
Benign
0.77
PhyloP100
1.8
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145101180; hg19: chr2-166896101; COSMIC: COSV57672968; COSMIC: COSV57672968; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.